Table 4.
Trait1 | Family | LG | Method2 and QTL position (cM) |
Marker3 | Marker position (cM)4 |
R2 (%) |
---|---|---|---|---|---|---|
Re | FamAS-2 | 4 | LR: 0/ML: 10 | Sma-USC47 | 0.00 | 7.4 |
FamAS-3 | 6 | LR: 0/ML: 26 | Sma-USC147 | 4.52 | 16.2 | |
FamAP | 5 | ML: 21 | SmaUSC-E30 | 0.00 | 8.9 | |
9 | LR: 31/ML: 38 | SmaUSC-E23 | 30.75 | 10.5 | ||
SmaUSC-E41 | 45.68 | 12.4 | ||||
Sma-USC21 | 53.91 | 11.6 | ||||
16 | ML: 35 | Sma-USC256 | 32.75 | 13.6 | ||
Su | FamAS-2 | 4 | LR: 0/ML: 10 | Sma-USC47 | 0.00 | 8.1 |
11 | LR: 43 | Sma-USC158 | 23.39 | 10.1 | ||
FamAS-3 | 6 | LR: 0/ML: 26 | Sma-USC147 | 4.52 | 16.8 | |
FamAP | 5 | ML: 19 | SmaUSC-E30 | 0.00 | 8.9 | |
9 | LR: 31/ML: 36 | SmaUSC-E23 | 30.75 | 12.3 | ||
SmaUSC-E41 | 45.68 | 12.8 | ||||
Sma-USC21 | 53.91 | 12.0 | ||||
16 | ML: 36 | Sma-USC256 | 32.75 | 12.4 |
1Re: resistance; Su: survival.
LG: linkage group.
2LR: linear regression method; ML: maximum likelihood method;
3BLAST annotation [17] was only recorded for Sma-USC23 (3-Hydroxibutirate dehydrogenase type 2) and Sma-USC41 (Helicase with zinc finger domain).
4Marker position in centimorgan (cM) within the genetic map by Bouza et al. [17].
R2 (%): proportion of the explained phenotypic variance.